Pharma Mar SA
MAD:PHM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharma Mar SA
MAD:PHM
|
ES |
|
A
|
Attendo AB (publ)
F:7AT
|
SE |
|
I
|
Infratil Ltd
XBER:IEE
|
NZ |
|
Aethlon Medical Inc
NASDAQ:AEMD
|
US |
|
Protector Forsikring ASA
OTC:PSKRF
|
NO |
|
Satori Resources Inc
XTSX:BUD
|
CA |
|
Impinj Inc
NASDAQ:PI
|
US |
|
H
|
Helen of Troy Ltd
XMUN:HT2
|
BM |
|
Coast Copper Corp
XTSX:COCO
|
CA |
|
Q
|
QTC Energy PCL
SET:QTC
|
TH |
|
88 Energy Ltd
OTC:EEEND
|
AU |
|
Platinex Inc
OTC:PANXF
|
CA |
|
Spartan Resources Ltd
ASX:SPR
|
AU |
|
China VTV Ltd
OTC:CVTV
|
HK |
|
L
|
Lancer Container Lines Ltd
NSE:LANCER
|
IN |
Wall St Price Targets
PHM Price Targets Summary
Pharma Mar SA
According to Wall Street analysts, the average 1-year price target for PHM is 102.12 EUR with a low forecast of 63.29 EUR and a high forecast of 131.25 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHM's stock price target?
Price Target
102.12
EUR
According to Wall Street analysts, the average 1-year price target for PHM is 102.12 EUR with a low forecast of 63.29 EUR and a high forecast of 131.25 EUR.
What is the Revenue forecast for Pharma Mar SA?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 13%.
What is the Gross Profit forecast for Pharma Mar SA?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 5 years is 17%.
What is the Operating Income forecast for Pharma Mar SA?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is 27%.
What is the Pre-Tax Income forecast for Pharma Mar SA?
Projected CAGR
48%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 48%.
What is the Net Income forecast for Pharma Mar SA?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 8 years is 19%.
